Cambridge Capital-Hugel deal published by China's SAMR for simple case review
MLex Summary: The proposed acquisition by Aphrodite Acquisition Holdings, a subsidiary of private equity firm Cambridge Capital, of a 43.02 percent stake in botulinum-toxin products supplier Hugel has been published for...To view the full article, register now.
Already a subscriber? Click here to view full article